// App-Quantinova.ai

TCT-216 : Bivalrudin vs. Argatroban for treatment of Heparin-induced Thrombocytopenia: A Meta-analysis

Researchers

Presenter

  • Poonam Velagapudi

Principal Investigators

  • Mohit Turagam

  • Mayank Mittal

  • Natraj Katta

  • Harsh Agrawal

  • Kul Aggarwal

  • J. Dawn Abbott

Medical Centers

  • Brown Medical School, Butler Hospital, Providence, Rhode Island, United States

  • University of Missouri School of Medicine, Columbia, Missouri, United States

  • Brown University/Alpert School of Medicine, Providence, Rhode Island, United States

  • Michigan State University, Kalamazoo, United States

  • University of Missouri, Columbia, Missouri, United States

  • Pathology, Texas Tech University HSC at El Paso, El Paso, Texas, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • Argatroban

  • Evithrom

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved